1 / 14

GM1 GANGLIOSIDOSIS TREATMENT MARKET ANALYSIS

Read here market analysis report on GM1 GANGLIOSIDOSIS

yuvhaan
Télécharger la présentation

GM1 GANGLIOSIDOSIS TREATMENT MARKET ANALYSIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/

  2. GM1 GANGLIOSIDOSIS TREATMENT MARKET ANALYSIS GM1 gangliosidosis is a progressive neurological genetic disorder mainly caused by the absence of a vital enzyme known as beta-galactosidase (GLB1). Without GLB1, a fatty substance called GM1 gangliosidosis accumulates in cells, and nerve cells of the brain. GM1 gangliosidosis is one of the 50 genetically inherited disorders known as lysosomal storage diseases. Currently, there is no treatment or cure for treatment of GM1 gangliosidosis.

  3. Market Dynamics Key players are focusing on strategic agreements in order to expand their presence in the market. For instance, in May 2017, Lysogene entered a strategic manufacturing agreement with Brammer Bio, a viral gene and cell therapy manufacturer. The agreement is expected to help Brammer Bio manufacture LYS-GM101, an AAVrh10- based gene therapy for the treatment of GM1 gangliosidosis.

  4. Key features of the study: • This report studies the current scenario as well as the future potential of the global GM1 gangliosidosis market. The market for GM1 gangliosidosis is segmented on the basis of product type, disease type, and region. • This report provides in-depth analysis of the global GM1 gangliosidosis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2025–2030) • It elucidates potential revenue opportunity across different

  5. segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players. • It profiles leading players in the global GM1 gangliosidosis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics • The global GM1 gangliosidosis market report caters to various

  6. stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global GM1 gangliosidosis market • Request free sample copy of gm1 gangliosidosis treatment market analysis • Request free PDF copy of gm1 gangliosidosis treatment market analysis

  7. Figure 1. Global GM1 Gangliosidosis Treatment Market Value (US$ Mn), 2025 - 2030

  8. Figure 2. Global GM1 Gangliosidosis Treatment Market Share (%), by Region, 2025

  9. Company Profiles: • Major players operating in the global GM1 Gangliosidosis Treatment market are Axovant Gene Therapies Ltd. and Passage Bio and Lysogene.

  10. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  11. CMI Services: • Talk to Analyst • CMI Services • CMI Latest Insights • CMI Blogs • CMI Press Releases

  12. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  13. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related